How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Implementing and delegated acts set out additional or detailed rules that help put EU law into practice. The Council of the European Union and the European Parliament can authorise the European ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

DOLE Building, Muralla corner General Luna Streets, Intramuros, Manila (Photo by Ramon FVelasquez via Wikimedia Commons CC BY-SA 4.0) The Department of Labor and Employment (DOLE) on Monday issued the ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...